Home / Stocks / Biocon Limited.
BIOCON

Biocon Limited. Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹363.65

Change

+1.7 (0.47%)

Open

₹361.2

Prev. Close

₹361.95

Day High

₹365.95

Day Low

₹359.15

Volume Analysis

Traded

2,516,134

Delivered

1,321,103

Delivery %

52.51%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (1)

  • •Strong operating margin (20.0%)

Weaknesses (2)

  • •Low return on equity (1.4%)
  • •Promoter holding is falling

Opportunities (1)

  • •FII holding has been rising

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹373.49 ₹369.72 ₹366.69 ₹362.92 ₹359.89 ₹356.12 ₹353.09
Fibonacci ₹369.72 ₹367.12 ₹365.52 ₹362.92 ₹360.32 ₹358.72 ₹356.12
Camarilla ₹365.52 ₹364.9 ₹364.27 ₹362.92 ₹363.03 ₹362.4 ₹361.78

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-6.22%

1 Week

-1.97%

1 Month

+8.55%

3 Months

-12.49%

6 Months

-15.48%

1 Year

-7.97%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹107.05

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

0.95%

Net margin 1.95% × asset turnover 0.26x × equity multiplier 1.87x

Company Overview

Sector

Healthcare

Market Cap

₹58,962 Cr

P/E (TTM)

86.5

ROE

1.4%

Book Value

₹214.0

Face Value

₹5.0

Source: Screener.in (Consolidated figures) — data as of 16 Nov 2026. Not investment advice.

TopFund Analysis

Biocon Limited. lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 55/100. The strongest factor is Financial Strength (91/100), while Valuation (25/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (20.0%); low return on equity (1.4%); promoter holding is falling. FII holding has been rising.

TopFund Score — Fundamentals Quality

55/100 — Average

Data confidence: 80/100 (High Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

91

Growth

42

Valuation

25

Cash Flow

42

Corporate Governance

76

Momentum

34

Institutional Ownership

78

Business Quality

42

Risk & Volatility

63

Liquidity

68

From Screener.in

  • −Company has low interest coverage ratio.
  • −Company has a low return on equity of 3.51% over last 3 years.
  • −Company might be capitalizing the interest cost
  • −Dividend payout has been low at 10.9% of profits over last 3 years

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 3,462 3,954 3,917 3,433 3,590 3,821 4,417 3,942 4,296 4,173 4,517 4,336 4,389
Expenses + 2,745 3,051 3,004 2,812 2,905 3,070 3,339 3,176 3,460 3,340 3,496 3,489 3,558
Operating Profit 717 903 913 620 685 752 1,078 766 835 834 1,020 847 831
OPM % 21.0% 23.0% 23.0% 18.0% 19.0% 20.0% 24.0% 19.0% 19.0% 20.0% 23.0% 20.0% 19.0%
Other Income + 134 587 40 1,166 58 53 57 62 81 -176 -28 41 28
Interest 248 267 227 236 226 223 212 277 272 210 232 213 240
Depreciation 389 414 407 405 420 425 436 455 473 515 513 547 564
Profit before tax 214 808 319 1,146 98 156 487 97 171 -68 248 128 55
Tax % 19.0% 7.0% 30.0% 25.0% 72.0% 48.0% 6.0% 8.0% 22.0% -24.0% 20.0% -7.0% -3.0%
Net Profit + 173 753 223 862 27 81 459 89 133 -52 199 137 57
EPS in Rs 1 6 1 5 0 0 3 0 1 1 1 1 0
Raw PDF — — — — — — — — — — — — —
YoY Sales growth 49 34 4 0 4 -3 13 15 20 9 2 10 2

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 3,090 3,347 3,891 4,123 5,514 6,300 7,143 8,184 11,174 14,756 15,262 16,927 17,414
Expenses + 2,394 2,957 2,912 3,294 4,121 4,696 5,562 6,391 8,762 11,540 12,008 13,456 13,883
Operating Profit 696 390 980 829 1,394 1,604 1,581 1,793 2,412 3,216 3,254 3,471 3,532
OPM % 23.0% 12.0% 25.0% 20.0% 25.0% 25.0% 22.0% 22.0% 22.0% 22.0% 21.0% 21.0% 20.0%
Other Income + 158 639 173 228 340 199 260 72 18 853 1,217 -76 -135
Interest 9 29 26 62 71 65 58 68 419 974 897 990 895
Depreciation 221 249 277 385 448 552 715 814 1,113 1,569 1,687 1,957 2,140
Profit before tax 624 751 850 610 1,215 1,186 1,068 983 897 1,525 1,887 448 362
Tax % 15.0% 19.0% 19.0% 26.0% 17.0% 27.0% 21.0% 22.0% 28.0% 15.0% 24.0% 18.0% —
Net Profit + 528 609 688 453 1,003 871 846 772 643 1,298 1,429 369 340
EPS in Rs 4 5 5 3 8 6 6 5 4 9 8 2 3
Dividend Payout % 20.0% 18.0% 10.0% 16.0% 7.0% 0.0% 0.0% 9.0% 39.0% 6.0% 6.0% 21.0% —
Sales growth 7 8 16 6 34 14 13 15 37 32 3 11 6

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 3,171 3,934 4,738 4,881 5,798 6,106 7,027 7,832 17,267 19,183 21,044 33,221 34,028
Borrowings + 1,117 2,478 2,302 2,264 2,422 2,715 4,481 5,147 18,019 16,277 18,362 15,434 15,698
Other Liabilities + 1,988 1,947 2,254 2,545 3,672 4,993 6,382 6,763 15,856 19,693 18,534 13,943 14,739
Total Liabilities 6,375 8,458 9,394 9,990 12,192 14,414 18,490 20,342 51,742 55,753 58,540 63,409 65,280
Fixed Assets + 1,630 1,748 3,626 3,700 4,471 5,971 6,364 6,569 29,468 30,644 31,963 36,486 39,689
CWIP 1,677 2,240 839 1,303 1,899 2,196 2,800 4,110 7,317 7,993 8,508 6,987 4,568
Investments 230 902 1,253 675 1,012 966 1,952 1,588 2,069 1,000 1,127 1,779 1,324
Other Assets + 2,839 3,569 3,676 4,312 4,811 5,281 7,374 8,074 12,888 16,117 16,941 18,157 19,699
Total Assets 6,375 8,458 9,394 9,990 12,192 14,414 18,490 20,342 51,742 55,753 58,540 63,409 65,280
Equity Capital 100 100 100 300 300 600 600 600 600 600 600 810 815

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 211 371 640 662 1,155 1,283 1,160 1,177 1,852 2,954 4,061 1,994
Cash from Investing Activity + -491 -1,138 -510 -684 -703 -1,505 -3,651 -1,662 -14,260 -1,002 -203 -1,883
Cash from Financing Activity + 186 1,068 -178 -240 -242 388 2,564 242 13,049 -2,333 -1,854 -924
Net Cash Flow -94 300 -47 -261 210 165 72 -243 641 -380 2,004 -812
Free Cash Flow -627 -246 32 -251 -337 -546 -577 -746 129 1,046 1,718 82
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 49 158 86 104 104 101 86 80 86 101 139 64

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 60.64% → 44.68%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Others 0.33% 0.32% 0.28% 0.25% 0.22% 0.21% 0.18% 0.14% 0.12% 0.09% 0.05% 0.19%
Public 17.96% 19.74% 18.9% 18.74% 18.11% 17.77% 16.51% 16.7% 16.34% 23.4% 23.75% 17.2%
Promoters 60.64% 60.64% 60.64% 60.64% 60.64% 60.64% 54.45% 54.45% 54.45% 44.91% 44.68% 44.68%
Government 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.03% 0.03% 0.05% 0.05% 0.08%
FII 6.55% 5.63% 5.9% 5.93% 5.66% 5.67% 6.04% 6.61% 7.39% 7.52% 8.14% 8.64%
DII 14.51% 13.69% 14.29% 14.44% 15.36% 15.73% 22.83% 22.06% 21.67% 24.01% 23.33% 29.22%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Biocon Limited. (this stock) 58,962 86.5 1.69 1.4%
Fortis Healthcare Ltd 61,047 56.9 5.81 11.2%
Alkem Laboratories Ltd. 61,875 28.6 4.16 18.9%
Aster Dm Quality Care Ltd 63,907 122.0 8.2 11.3%
Gland Pharma Limited 53,710 42.9 5.01 10.7%
Anthem Biosciences Ltd 51,355 81.4 15.65 22.3%
Ipca Laboratories Ltd 46,508 32.3 5.36 15.7%

Which Mutual Funds Hold Biocon Limited.?

Frequently Asked Questions about Biocon Limited.

Community Sentiment

What are other investors saying about Biocon Limited.?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.